Home › Companies › Twist Bioscience Corporation › 2025-2026

Twist Bioscience Corporation 2025-2026 Proxy Voting Records

Compiled from SEC Form N-PX filings and Twist Bioscience Corporation’s Form 8-K, filed 2026-02-06 (Item 5.07 on EDGAR). Page generated 04 October 2026.

7Reported items
278Asset managers
1,468Fund votes
2026-02-05Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore Twist Bioscience Corporation in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by Twist Bioscience Corporation

These tallies are Twist Bioscience Corporation’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2026-02-06 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

Twist Bioscience Corporation — official shareholder meeting results, meeting held 2026-02-05
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Outcome
Elect Director: Keith Crandell	40,500,506	--	--	9,805,197	5,954,803	Majority: yes
Elect Director: Jan Johannessen	42,319,597	--	--	7,986,106	5,954,803	Majority: yes
Elect Director: Trynka Shineman Blake	50,217,493	--	--	88,210	5,954,803	Majority: yes

Source: Twist Bioscience Corporation, Form 8-K, filed with the SEC on 2026-02-06 — read the filing on EDGAR.

How asset managers voted at the Twist Bioscience Corporation 2025-2026 meeting

Each item below shows how the 278 asset managers that disclosed a Twist Bioscience Corporation vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Twist Bioscience Corporation’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. To adopt, on an advisory basis, a resolution approving the compensation of the Company's Named Executive Officers, as described in the Proxy Statement under "Executive Compensation."

SECTION 14A SAY-ON-PAY VOTES

Combines 7 wordings of this item as funds reported it.

70% fund support · no official result

FOR 70%AGAINST 30%

The 272 asset managers below cast 70% of the shares they voted on this item FOR (34,105,860 for, 14,648,986 against).

FOR: 34,105,860 (69.9%)AGAINST: 14,648,986 (30.0%)ABSTAIN: 9,489 (0.0%)

Largest asset managers voting on “To adopt, on an advisory basis, a resolution approving the compensation of the Company's Named Executive Offic” at Twist Bioscience Corporation, 2025-2026
Asset manager	For	Against	Vote
ARK ETF Trust	6,627,917	0	For
Vanguard	2,999,202	2,747,356	For
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC	4,562,883	0	For
Artisan	4,219,930	0	For
BlackRock	3,208,959	20,016	For
Thrivent	0	2,715,638	Against
Amova Asset Management Co., Ltd.	0	1,902,829	Against
Invesco	0	1,865,219	Against
American Century	0	1,400,714	Against
State Street	1,229,890	9,548	For
WILLIAM BLAIR FUNDS	1,163,607	0	For
First Light Asset Management, LLC	1,131,281	0	For
Charles Schwab	1,093,553	0	For
BAILLIE GIFFORD & CO LTD	845,222	0	For
Bridge Builder Trust	693,579	12,039	For
Freshford Capital Management, LLC	616,475	0	For
ARK Investment Management LLC	458,188	0	For
Soleus Capital Management, L.P.	398,064	0	For
JENNISON ASSOCIATES LLC	361,935	0	For
Aberdeen	308,116	0	For
Northern Trust	290,916	12,677	For
Fidelity	302,191	0	For
Baillie Gifford Investment Management (Europe) Ltd	293,583	0	For
Nuveen	290,556	0	For
TIAA	284,199	0	For

Showing the 25 largest of 272 asset managers. See all 272 in the interactive database.

2. Election of Class II Directors: Jan Johannessen

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 6 wordings of this item as funds reported it.

84% Majority: yes · of votes cast

FOR 84%WITHHELD 16%

FOR: 42,319,597WITHHELD: 7,986,106

Twist Bioscience Corporation’s own tally for this item (“Elect Director: Jan Johannessen”): 42,319,597 for, 7,986,106 withheld, per its Form 8-K filed 2026-02-06 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 61,311,704 outstanding shares: 69% for, 13% withheld (82% of the company cast a for/withheld vote).

The 75 asset managers below cast 100% of the shares they voted on this item FOR (18,709,055 for, 0 against).

FOR 86%ABSTAIN 14%

FOR: 18,709,055 (85.9%)ABSTAIN: 3,063,338 (14.1%)

Largest asset managers voting on “Election of Class II Directors: Jan Johannessen” at Twist Bioscience Corporation, 2025-2026
Asset manager	For	Abstain	Vote
ARK ETF Trust	6,627,917	0	For
Vanguard	5,240,051	550	For
BlackRock	1,398,072	0	For
Thrivent	0	1,353,808	Abstain
WILLIAM BLAIR FUNDS	1,163,607	0	For
Invesco	799,105	0	For
Bridge Builder Trust	693,579	12,039	For
State Street	672,251	705	For
American Century	0	664,961	Abstain
Charles Schwab	546,571	0	For
Fidelity	289,094	0	For
TIAA	284,199	0	For
PROFESSIONALLY MANAGED PORTFOLIOS	0	191,720	Abstain
Equitable	88,180	44,531	For
AMERICAN BEACON FUNDS	132,163	0	For
Allspring	0	119,907	Abstain
Victory Capital	0	114,743	Abstain
MassMutual	103,125	0	For
AIG/SunAmerica	0	101,876	Abstain
QUANTITATIVE MASTER SERIES LLC	100,823	0	For
Direxion Shares ETF Trust	0	84,583	Abstain
Lincoln Financial	43,588	39,033	For
OPTIMUM FUND TRUST	80,106	0	For
ARK Venture Fund	68,679	0	For
Neuberger Berman	66,754	0	For

Showing the 25 largest of 75 asset managers. See all 75 in the interactive database.

3. Election of Class II Directors: Keith Crandell

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 6 wordings of this item as funds reported it.

81% Majority: yes · of votes cast

FOR 81%WITHHELD 19%

FOR: 40,500,506WITHHELD: 9,805,197

Twist Bioscience Corporation’s own tally for this item (“Elect Director: Keith Crandell”): 40,500,506 for, 9,805,197 withheld, per its Form 8-K filed 2026-02-06 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 61,311,704 outstanding shares: 66% for, 16% withheld (82% of the company cast a for/withheld vote).

The 75 asset managers below cast 100% of the shares they voted on this item FOR (17,756,438 for, 0 against).

FOR 82%ABSTAIN 18%

FOR: 17,756,438 (81.6%)ABSTAIN: 4,015,955 (18.4%)

Largest asset managers voting on “Election of Class II Directors: Keith Crandell” at Twist Bioscience Corporation, 2025-2026
Asset manager	For	Abstain	Vote
ARK ETF Trust	6,627,917	0	For
Vanguard	5,240,051	550	For
BlackRock	1,398,072	0	For
Thrivent	0	1,353,808	Abstain
WILLIAM BLAIR FUNDS	1,163,607	0	For
Invesco	0	799,105	Abstain
Bridge Builder Trust	693,579	12,039	For
State Street	672,251	705	For
American Century	0	664,961	Abstain
Charles Schwab	546,571	0	For
Fidelity	289,094	0	For
TIAA	284,199	0	For
PROFESSIONALLY MANAGED PORTFOLIOS	0	191,720	Abstain
Equitable	88,180	44,531	For
AMERICAN BEACON FUNDS	132,163	0	For
Allspring	0	119,907	Abstain
Victory Capital	0	114,743	Abstain
MassMutual	0	103,125	Abstain
AIG/SunAmerica	0	101,876	Abstain
QUANTITATIVE MASTER SERIES LLC	100,823	0	For
Direxion Shares ETF Trust	0	84,583	Abstain
Lincoln Financial	43,588	39,033	For
OPTIMUM FUND TRUST	80,106	0	For
ARK Venture Fund	68,679	0	For
Neuberger Berman	66,754	0	For

Showing the 25 largest of 75 asset managers. See all 75 in the interactive database.

4. Election of Class II Directors: Trynka Shineman Blake

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 6 wordings of this item as funds reported it.

99.8% Majority: yes · of votes cast

FOR 99.8%

FOR: 50,217,493WITHHELD: 88,210

Twist Bioscience Corporation’s own tally for this item (“Elect Director: Trynka Shineman Blake”): 50,217,493 for, 88,210 withheld, per its Form 8-K filed 2026-02-06 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 61,311,704 outstanding shares: 82% for, 0.2% withheld (82% of the company cast a for/withheld vote).

The 75 asset managers below cast 100% of the shares they voted on this item FOR (21,762,989 for, 0 against).

FOR 99.9%

FOR: 21,762,989 (100.0%)ABSTAIN: 9,404 (0.0%)

Largest asset managers voting on “Election of Class II Directors: Trynka Shineman Blake” at Twist Bioscience Corporation, 2025-2026
Asset manager	For	Vote
ARK ETF Trust	6,627,917	For
Vanguard	5,240,601	For
BlackRock	1,398,072	For
Thrivent	1,353,808	For
WILLIAM BLAIR FUNDS	1,163,607	For
Invesco	799,105	For
Bridge Builder Trust	705,618	For
State Street	672,956	For
American Century	664,961	For
Charles Schwab	546,571	For
Fidelity	289,094	For
TIAA	284,199	For
PROFESSIONALLY MANAGED PORTFOLIOS	191,720	For
Equitable	132,711	For
AMERICAN BEACON FUNDS	132,163	For
Allspring	119,907	For
Victory Capital	114,743	For
MassMutual	103,125	For
AIG/SunAmerica	101,876	For
QUANTITATIVE MASTER SERIES LLC	100,823	For
Direxion Shares ETF Trust	84,583	For
Lincoln Financial	82,621	For
OPTIMUM FUND TRUST	80,106	For
ARK Venture Fund	68,679	For
Neuberger Berman	66,754	For

Showing the 25 largest of 75 asset managers. See all 75 in the interactive database.

5. TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING SEPTEMBER 30, 2026.

AUDIT-RELATED

100% fund support · no official result

FOR 99.9%

The 73 asset managers below cast 100% of the shares they voted on this item FOR (21,757,433 for, 0 against).

FOR: 21,757,433 (100.0%)ABSTAIN: 9,404 (0.0%)

Largest asset managers voting on “TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FI” at Twist Bioscience Corporation, 2025-2026
Asset manager	For	Vote
ARK ETF Trust	6,627,917	For
Vanguard	5,240,601	For
BlackRock	1,398,072	For
Thrivent	1,353,808	For
WILLIAM BLAIR FUNDS	1,163,607	For
Invesco	799,105	For
Bridge Builder Trust	705,618	For
State Street	672,956	For
American Century	664,961	For
Charles Schwab	546,571	For
Fidelity	289,094	For
TIAA	284,199	For
PROFESSIONALLY MANAGED PORTFOLIOS	191,720	For
Equitable	132,711	For
AMERICAN BEACON FUNDS	132,163	For
Allspring	119,907	For
Victory Capital	114,743	For
MassMutual	103,125	For
AIG/SunAmerica	101,876	For
QUANTITATIVE MASTER SERIES LLC	100,823	For
Direxion Shares ETF Trust	84,583	For
Lincoln Financial	82,621	For
OPTIMUM FUND TRUST	80,106	For
ARK Venture Fund	68,679	For
Neuberger Berman	66,754	For

Showing the 25 largest of 73 asset managers. See all 73 in the interactive database.

6. Advisory Vote to Ratify Named Executive Officers' Compensation

SECTION 14A SAY-ON-PAY VOTES

2% fund support · no official result

AGAINST 98%

The 3 asset managers below cast 2% of the shares they voted on this item FOR (95 for, 5,556 against).

FOR: 95 (1.7%)AGAINST: 5,556 (98.3%)

Largest asset managers voting on “Advisory Vote to Ratify Named Executive Officers' Compensation” at Twist Bioscience Corporation, 2025-2026
Asset manager	For	Against	Vote
JPMorgan	0	3,676	Against
CLEARWATER INVESTMENT TRUST	0	1,880	Against
LOUISBOURG INVESTMENTS INC.	95	0	For

7. Ratify Ernst & Young LLP as Auditors

AUDIT-RELATED

100% fund support · no official result

FOR 100%

The 2 asset managers below cast 100% of the shares they voted on this item FOR (5,556 for, 0 against).

FOR: 5,556 (100.0%)

Largest asset managers voting on “Ratify Ernst & Young LLP as Auditors” at Twist Bioscience Corporation, 2025-2026
Asset manager	For	Against	Abstain	Withheld	Vote
JPMorgan	3,676	0	0	0	For
CLEARWATER INVESTMENT TRUST	1,880	0	0	0	For

Largest Twist Bioscience Corporation shareholders voting in 2025-2026

Ranked by the number of Twist Bioscience Corporation shares each manager voted on the most widely held ballot item of the 2025-2026 meeting, shown as a share of the 61,311,704 shares outstanding at the time of that meeting.

Top Twist Bioscience Corporation shareholders by shares voted, 2025-2026
#	Asset manager	% of shares outstanding
1	ARK ETF Trust	10.81%
2	Vanguard	9.37%
3	WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC	7.44%
4	Artisan	6.88%
5	BlackRock	5.27%
6	Thrivent	4.43%
7	Amova Asset Management Co., Ltd.	3.10%
8	Invesco	3.04%
9	American Century	2.28%
10	State Street	2.02%

Reported Twist Bioscience Corporation ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

Twist Bioscience Corporation beneficial owners on record for the 2025-2026 proxy season
Holder	% outstanding	Disclosure
Vanguard Group	9.42%	13F
BlackRock	9.06%	13F
Artisan Partners Asset Management Inc.	7.83%	13G
State Street	5.99%	13F
T. Rowe Price Associates, Inc.	5.93%	13G
ARK Investment Management LLC	5.52%	13G
EdgePoint Investment Group Inc.	4.11%	13G
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC	3.55%	13G
Invesco	3.54%	13F
FMR (Fidelity)	3.08%	13F

Percentages above are of 61,311,704 shares outstanding, as reported by Twist Bioscience Corporation on its Form 10-Q dated 2026-01-27 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Twist Bioscience Corporation’s 10-Q dated 2026-01-27. This page is a static snapshot rebuilt weekly on 04 October 2026; a live search always shows the current data.

At Twist Bioscience Corporation's shareholder meeting held 2026-02-05, in the 2025-2026 proxy season, 278 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,468 separate fund positions. Their filings are grouped here into 7 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. Twist Bioscience Corporation's own Form 8-K tally for this meeting is published below, but no row in it could be matched to the most widely held item, so this page states no certified outcome for that item. On that item — To adopt, on an advisory basis, a resolution approving the compensation of the Company's Named… — the reporting funds cast 70% of the shares they voted in favour (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). That is the aggregate of those managers' own N-PX disclosures, not the company's certified result, and the funds are a subset of all shareholders.

Twist Bioscience Corporation proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).